Number of the records: 1  

polyradikuloneuropatia chronická zápalová demyelinizačná

  1. SYSd020277
    LBL
      
    00000nx--j22000003--45--
    005
      
    20240119200313.1
    100
      
    $a 19991105csloy0103----ba0
    152
      
    $b mesh
    250
      
    $a polyradikuloneuropatia chronická zápalová demyelinizačná $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $8 slo
    300
    1-
    $a 2000 $8 eng
    300
    1-
    $a Polyradiculopathy (1975-1999) $8 eng
    330
    1-
    $a A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. (Adams et al., Principles of Neurology, 6th ed, p1337) $8 eng
    450
      
    $a CIDP $5 e $8 eng
    450
      
    $a CIDP $5 e $8 slo
    450
      
    $a polyneuropatia chronická zápalová demyelinizačná $5 e $8 slo
    686
      
    $a C10.114.750.175
    686
      
    $a C10.314.750.700
    686
      
    $a C10.668.829.800.750.600
    686
      
    $a C20.111.258.750.800
    686
      
    $a C23.550.291.500.813
    750
      
    $a Polyradiculoneuropathy, Chronic Inflammatory Demyelinating $8 eng
    801
    -0
    $a US $b DNLM $c 19991105
    801
    -2
    $a SK $b BA006 $c 20030515
    820
      
    $a do not confuse entry term CHRONIC INFLAMMATORY POLYRADICULONEUROPATHY with POLYRADICULONEUROPATHY, ACUTE INFLAMMATORY see GUILLAIN-BARRE SYNDROME $8 eng
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.